Vasundhara Rasayans Ltd manufacturing and exporter Antacids therapeutic category of Active Pharm IngredientsBusiness Overview: Company offers wide range antacid therapeutic category of API andis also having an API intermediate plant to handle organic product
Scrutinizer''s Report on the remote e-voting as well as e-voting (Insta-Poll) during the AGM, issued by Mrs. Rakhi Agarwal, Practising Company secretary, Scrutinizer
Summary of proceedings of the 39th Annual General Meeting of the Company is attached
VASUNDHARA RASAYANS LTD. has published its financial results for the quarter ended June 30, 2026. The company's total income for the quarter was 73001. Profit before tax for the period stood at 6480, showing growth from 5128 in the corresponding quarter of the previous year. Net profit for the period...
Vasundhara Rasayans' board has approved Q1 results. The company reported Net Sales of ₹6.93 Cr & Net Profit of ₹0.65 Cr for the quarter. EPS stood at ₹2.04.
